CATALANO, GIANFRANCO

CATALANO, GIANFRANCO  

Dipartimento di Biomedicina e Prevenzione  

Mostra records
Risultati 1 - 20 di 40 (tempo di esecuzione: 0.019 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-1988 [Current aspects of treatment of multiple myeloma] Tribalto, M; Avvisati, G; Cantonetti, M; Catalano, G; Giovangrossi, P; Masi, M; Petrucci, M; Venditti, A; Papa, G Articolo su rivista
23-giu-2016 A case of SRSF2 mutation in chronic lymphocytic leukemia Garza, E; DEL POETA, G; Martinez Losada, C; Catalano, G; Borgia, L; Piredda, M; Fabiani, E; Gattei, V; LO COCO, F; Noguera, Ni Articolo su rivista
1-giu-1997 A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype Stasi, R; Bruno, A; Venditti, A; DEL POETA, G; Aronica, G; Cox, M; Maffei, L; Catalano, G; Zangrilli, D; Amadori, S Articolo su rivista
16-mar-2020 Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration Banella, C; Ginevrino, M; Catalano, G; Fabiani, E; Falconi, G; Divona, M; Curzi, P; Panetta, P; Voso, Mt; Noguera, Ni Articolo su rivista
1-ott-2019 Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt Articolo su rivista
23-mag-2022 Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment Banella, C; Catalano, G; Travaglini, S; Pelosi, E; Ottone, T; Zaza, A; Guerrera, G; Angelini, Df; Niscola, P; Divona, M; Battistini, L; Screnci, M; Ammatuna, E; Testa, U; Nervi, C; Voso, Mt; Noguera, Ni Articolo su rivista
1-gen-2007 Benzodiazepine derivatives and uses thereof in medical field SINIBALDI SALIMEI, P; Silvestri, R; Marfè, G; Abbruzzese, E; Catalano, G; Di Stefano, C; Novellino, E; La Regina, G; Lavecchia, A Brevetti
1-gen-2013 Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy Niscola, P; Catalano, G; Tendas, A; Giovannini, M; Scaramucci, L; Neri, B; Morino, L; Piccioni, D; Fratoni, S; Perrotti, A; DE FABRITIIS, P Articolo su rivista
1-set-2013 Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis Niscola, P; Catalano, G; Fratoni, S; Scaramucci, L; DE FABRITIIS, P; Caravita, T Articolo su rivista
1-ago-2017 Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. Niscola, P; Neri, B; Catalano, G; Morino, L; Giovannini, M; Scaramucci, L; Fratoni, S; Noguera, N; Cordone, I; de Fabritiis, P Articolo su rivista
1-ott-2017 Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. Niscola, P; Abruzzese, E; Trawinska, M; Palombi, M; Tendas, A; Giovannini, M; Scaramucci, L; Cupelli, L; Fratoni, S; Noguera, N; Catalano, G; de Fabritiis, P Articolo su rivista
24-ott-2014 Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes Garza, E; Fabiani, E; Noguera, Ni; Panetta, P; Piredda, M; Borgia, L; Maurillo, L; Catalano, G; Voso, Mt; LO COCO, F Articolo su rivista
1-apr-1994 Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins Chan, A; Mcgovern, E; Catalano, G; Fleming, T; Miki, T Articolo su rivista
1-gen-2017 High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro Noguera, N; Pelosi, E; Angelini, D; Piredda, M; Guerrera, G; Piras, E; Battistini, L; Massai, L; Berardi, A; Catalano, G; Cicconi, L; Castelli, G; D'Angio, A; Pasquini, L; Graziani, G; Fioritoni, G; Voso, Mt; Mastrangelo, D; Testa, U; Lo Coco, F Articolo su rivista
1-gen-2017 Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms Piredda, M; Catalano, G; Ciardi, C; Divona, M; Cicconi, L; Panetta, P; Curzi, P; Garza, E; Martinez Losada, C; Postorino, M; LO COCO, F; Noguera, Ni Articolo su rivista
1-lug-2004 Imatinib-mesylate for all patients with hypereosinophilic syndrome? Musto, P; Perla, G; Minervini, M; Carella, A; LO COCO, F; Catalano, G Articolo su rivista
1-gen-2004 Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant DI STEFANO, C; Abruzzese, E; Marfe, G; Silvestri, R; Catalano, G; Trawinska, M; SINIBALDI SALIMEI, P; Amadori, S Articolo su rivista
1-gen-2004 Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant DI STEFANO, C; Abruzzese, E; Marfe, G; Silvestri, R; Catalano, G; Trawinska, M; SINIBALDI SALIMEI, P; Amadori, S Articolo su rivista
1-dic-2000 Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia Venditti, A; Buccisano, F; DEL POETA, G; Maurillo, L; Tamburini, A; Cox, C; Battaglia, A; Catalano, G; Del Moro, B; Cudillo, L; Postorino, M; Masi, M; Amadori, S Articolo su rivista
1-giu-2014 Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy Niscola, P; Tendas, A; Scaramucci, L; Merola, R; Catalano, G; DE FABRITIIS, P Articolo su rivista